申请人:Kyorin Pharmaceutical Co., Ltd.
公开号:US05786486A1
公开(公告)日:1998-07-28
Acrylamide derivatives represented by General Formula (1) below: ##STR1## (One specific example of General Formula (1) is methyl (S,S)-3,3'-\x9b3,3'-(1,4-phenylenediacryloyl)!-bis\x9b1-chloromethyl-5-hydroxy-7 -triflouromethyl-1, 2,3,6-tetrahydropyrrolo\x9b3,2-e!indole-8-carboxylate.) The acrylamide derivatives represented by General Formula (1) is highly selective to cancer cells, less toxic, and highly active also against solid tumor.
以下是通式(1)所代表的丙烯酰胺衍生物: ##STR1## (通式(1)的一个具体例子是甲基(S,S)-3,3'-\x9b3,3'-(1,4-苯二酰亚胺)!-bis\x9b1-氯甲基-5-羟基-7-三氟甲基-1,2,3,6-四氢吡咯\x9b3,2-e!吲哚-8-羧酸酯。)通式(1)所代表的丙烯酰胺衍生物对癌细胞具有高度选择性,毒性较小,并且对实体肿瘤也具有高活性。